Alcohol Intake and Alcohol-SNP Interactions Associated with Prostate Cancer Aggressiveness.

SNP interaction alcohol intake prostate cancer

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
02 Feb 2021
Historique:
received: 03 12 2020
revised: 25 01 2021
accepted: 28 01 2021
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 6 2 2021
Statut: epublish

Résumé

Excessive alcohol intake is a well-known modifiable risk factor for many cancers. It is still unclear whether genetic variants or single nucleotide polymorphisms (SNPs) can modify alcohol intake's impact on prostate cancer (PCa) aggressiveness. The objective is to test the alcohol-SNP interactions of the 7501 SNPs in the four pathways (angiogenesis, mitochondria, miRNA, and androgen metabolism-related pathways) associated with PCa aggressiveness. We evaluated the impacts of three excessive alcohol intake behaviors in 3306 PCa patients with European ancestry from the PCa Consortium. We tested the alcohol-SNP interactions using logistic models with the discovery-validation study design. All three excessive alcohol intake behaviors were not significantly associated with PCa aggressiveness. However, the interactions of excessive alcohol intake and three SNPs (rs13107662 [

Identifiants

pubmed: 33540941
pii: jcm10030553
doi: 10.3390/jcm10030553
pmc: PMC7867322
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R21 CA202417
Pays : United States
Organisme : NCI NIH HHS
ID : R21CA202417
Pays : United States

Déclaration de conflit d'intérêts

All authors disclosed no potential conflicts of interest.

Références

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):305-310
pubmed: 28417982
Int J Cancer. 2003 Jan 20;103(3):306-15
pubmed: 12471613
Nat Rev Cancer. 2007 Aug;7(8):599-612
pubmed: 17646865
J Urol. 1995 Jul;154(1):293-8
pubmed: 7539865
Mol Carcinog. 2020 Aug;59(8):930-939
pubmed: 32367578
Arch Gen Psychiatry. 2009 Jul;66(7):773-84
pubmed: 19581569
Alcohol Clin Exp Res. 2010 May;34(5):840-52
pubmed: 20201924
J Clin Invest. 1999 Feb;103(3):313-20
pubmed: 9927491
Blood. 2006 Nov 1;108(9):3068-71
pubmed: 16849646
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1282-7
pubmed: 18483352
Cancer Causes Control. 2016 Sep;27(9):1049-58
pubmed: 27351919
Exp Ther Med. 2016 Aug;12(2):925-932
pubmed: 27446297
BMC Cancer. 2016 Nov 15;16(1):845
pubmed: 27842506
Clin Cancer Res. 2008 Sep 15;14(18):5931-7
pubmed: 18794107
Clin Cancer Res. 2005 Nov 1;11(21):7658-63
pubmed: 16278385
Mol Psychiatry. 2015 Aug;20(8):1002-10
pubmed: 25266122
Transl Cancer Res. 2016 Oct;5(Suppl 5):S951-S963
pubmed: 28664150
Oncol Rep. 2020 Oct;44(4):1671-1685
pubmed: 32945508
Pathol Oncol Res. 2019 Oct;25(4):1285-1293
pubmed: 30610466
Cancer Lett. 2006 Sep 28;241(2):159-73
pubmed: 16442709
Oncogene. 2014 May 8;33(19):2495-503
pubmed: 23728339
Gut. 2016 Jul;65(7):1175-85
pubmed: 26078290
Nat Genet. 2013 Apr;45(4):385-91, 391e1-2
pubmed: 23535732
Development. 2003 Oct;130(20):4769-84
pubmed: 12952899
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Clin Oncol. 2016 Jun 1;34(16):1913-20
pubmed: 27044933
J Clin Oncol. 2019 Jun 10;37(17):1499-1511
pubmed: 31026211
Biochem Biophys Res Commun. 1996 Nov 12;228(2):646-52
pubmed: 8920963
Lancet. 2003 Mar 8;361(9360):859-64
pubmed: 12642065
Exp Oncol. 2010 Jul;32(2):66-70
pubmed: 20693964
Int J Cancer. 2017 Jan 1;140(1):75-85
pubmed: 27643404
Ann Surg Oncol. 2015 Feb;22(2):630-5
pubmed: 25145502
Am J Pathol. 1996 Feb;148(2):539-48
pubmed: 8579116
Trends Pharmacol Sci. 2010 Jan;31(1):8-14
pubmed: 19969380
World J Surg Oncol. 2013 Aug 27;11:213
pubmed: 23981902
Anatol J Cardiol. 2018 Jan;19(1):19-26
pubmed: 29339696
Cell. 2000 Oct 13;103(2):211-25
pubmed: 11057895
Oncol Rep. 2006 Jun;15(6):1437-43
pubmed: 16685377
Carcinogenesis. 2002 Mar;23(3):381-7
pubmed: 11895852
Gene. 2011 Dec 10;489(2):119-29
pubmed: 21920414
Lancet Oncol. 2006 Feb;7(2):149-56
pubmed: 16455479
Cancer Lett. 2003 Jan 10;189(1):97-102
pubmed: 12445683
Cereb Cortex. 2013 Jun;23(6):1495-508
pubmed: 22661412
Alcohol Clin Exp Res. 2016 Jul;40(7):1524-30
pubmed: 27177528
Asian J Androl. 2013 Mar;15(2):226-30
pubmed: 23353719
Biomed Res Int. 2014;2014:627510
pubmed: 24701578
Obesity (Silver Spring). 2016 Jun;24(6):1336-41
pubmed: 27106561
Oncotarget. 2010 Jul;1(3):198-209
pubmed: 21301049
Science. 2003 Jan 10;299(5604):247-51
pubmed: 12522250
Genet Epidemiol. 2016 Jul;40(5):356-65
pubmed: 27061572
Pathol Oncol Res. 2014 Jul;20(3):517-9
pubmed: 24272677
Hepatology. 2018 Sep;68(3):1125-1139
pubmed: 29537660
J Genet. 2016 Sep;95(3):551-63
pubmed: 27659325
PLoS One. 2013 Apr 03;8(4):e59688
pubmed: 23593148
Hum Brain Mapp. 2015 Aug;36(8):3007-19
pubmed: 25939814
Cancers (Basel). 2017 Apr 10;9(4):
pubmed: 28394264
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901
pubmed: 27899670
Cancer Res. 2006 Mar 15;66(6):3114-9
pubmed: 16540661
Int J Cancer. 2014 Dec 1;135(11):2493-506
pubmed: 24752651
Cancer Res. 2017 Jan 15;77(2):378-389
pubmed: 27821488
Oncogene. 2002 May 2;21(19):3020-8
pubmed: 12082532
Genes Brain Behav. 2017 Jan;16(1):139-148
pubmed: 27906494
Nature. 2000 Aug 17;406(6797):742-7
pubmed: 10963601
Am J Pathol. 1995 Aug;147(2):386-96
pubmed: 7639332
Int J Cancer. 2018 Apr 1;142(7):1322-1331
pubmed: 29168174
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6626-31
pubmed: 21464311
Pharmacol Biochem Behav. 2008 Jun;89(4):481-98
pubmed: 18405950
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Transl Cancer Res. 2019 Jan;8(Suppl 4):S334-S345
pubmed: 31497514
Alcohol Clin Exp Res. 2012 Jun;36(6):1021-33
pubmed: 22150570
Cancer Res. 2006 Sep 15;66(18):9065-73
pubmed: 16982748
Cancer Epidemiol. 2016 Dec;45:11-17
pubmed: 27664387
Acta Med Indones. 2016 Jul;48(3):228-238
pubmed: 27840359
Genes Dev. 2008 May 15;22(10):1276-312
pubmed: 18483217
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1131-45
pubmed: 21447778

Auteurs

Hui-Yi Lin (HY)

Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Xinnan Wang (X)

Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Tung-Sung Tseng (TS)

Behavioral and Community Health Sciences Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Yu-Hsiang Kao (YH)

Behavioral and Community Health Sciences Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Zhide Fang (Z)

Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Patricia E Molina (PE)

Department of Physiology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Comprehensive Alcohol Research Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Chia-Ho Cheng (CH)

Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Anders E Berglund (AE)

Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Rosalind A Eeles (RA)

The Institute of Cancer Research, and The Royal Marsden NHS Foundation Trust, London, SM2 5NG, UK.

Kenneth R Muir (KR)

Division of Population Health, Health Services Research, and Primary Care, University of Manchester, Oxford Road, Manchester, M139PT, UK.

Nora Pashayan (N)

Department of Applied Health Research, University College London, WC1E 7HB, London, UK.

Christopher A Haiman (CA)

Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), D-69120 Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.

The Practical Consortium (TP)

The Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome Consortium (PRACTICAL, http://practical.icr.ac.uk/), London SM2 5NG, UK. Additional members from The PRACTICAL Consortium were provided in the Supplement.

Jong Y Park (JY)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Classifications MeSH